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Objectives. To examine the extent to which measures of adiposity can be used to predict selected components of metabolic
syndrome (MetS) and elevated C-reactive protein (CRP). Methods. A total of 1,518 Peruvian adults were included in this study.
Waist circumference (WC), body mass index (BMI), waist-hip ratio (WHR), waist-height ratio (WHtR), and visceral adiposity
index (VAI)were examined. The prevalence of each MetS componentwasdetermined according to tertiles of each anthropometric
measure. ROC curves were used to evaluate the extent to which measures of adiposity can predict cardiovascular risk. Results.A l l
measuresofadiposityhadthestrongestcorrelationwithtriglyceride concentrations(TG).Forbothgenders,asadiposityincreased,
the prevalence of Mets components increased. Compared to individuals with low-BMI and low-WC, men and women with high-
BMI and high- WC had higher odds of elevated fasting glucose, blood pressure, TG, and reduced HDL, while only men in this
category had higher odds of elevated CRP. Overall, the ROCs showed VAI, WC, and WHtR to be the best predictors for individual
MetS components. Conclusions. The results of our study showed that measures of adiposity are correlated with cardiovascular risk
although no single adiposity measure was identiﬁed as the best predictor for MetS.
1.Introduction
Worldwide, cardiovascular disease (CVD) is the primary
cause of death; it killed an estimated 17.1 million people in
2004 [1, 2]. Historically, CVD was thought to be a disease
endemic to developed countries only [3]; however, new evi-
dence indicates that developing countries are more strongly
aﬀectedbyCVDthantheirmoreaﬄuentcounterparts[1–3].
The presence of metabolic syndrome (MetS) is a major
risk factor for CVD [4]. According to the third report of
the national cholesterol education program (NCEP) expert
panel on detection, evaluation, and treatment of high blood
cholesterol in adults, MetS is deﬁned as a co-occurrence
of speciﬁc health states, including elevated triglyceride con-
centrations (TG), reduced high-density lipoprotein (HDL),
elevated blood pressure (BP), elevated fasting glucose (FG),
and high waist circumference (WC) [5]. Body mass index
(BMI), WC, Waist-to-hip ratio (WHR), waist-height ratio
(WHtR)[6],andvisceraladiposityindex(VAI)[7]havebeen
reported as similarly predictive for the presence of MetS in
men and women.
Obesity is deﬁned by the World Health Organization
(WHO) as BMI > 30kg/m2, and overweight is classiﬁed as
BMI > 25kg/m2 [8].TheestablishedBMIcut-oﬀpointswere
designed for international use. Because of the concern that
BMI cut-oﬀs points might not accurately predict health risks2 International Journal of Hypertension
in all populations, the WHO established a commission and
charged participants with examining available data about
WC and WHR [9]. In light of concerns raised about the
ability of BMI alone to predict cardiovascular risk, multiple
studies have recently attempted to compare BMI with WC
and other anthropometric measures of obesity, such as
WHR, WHtR, and VAI, as predictors for CVD risk. In
a meta-analysis of abdominal obesity indices comparing
BMI, WC, WHR, and WHtR, researchers concluded that
WHtR was the best predictor for both hypertension and
dyslipidemia for both men and women, while BMI was the
leastaccuratepredictorofhypertension [10].Whenassessing
the accuracy of VAI in comparison to BMI and WC using
receiver operating characteristic (ROC) curves, Amato and
colleagues found VAI to be independently associated with
cardiovascular events, while BMI and WC were not found to
be signiﬁcant discriminators [7].
Between 2000 and 2009 among Peruvians aged 15 or
older, 11.5% of men and 12.5% of women were obese [11].
A recent study in Lima found the prevalence of MetS to
be 21.6% in men and 29.9% in women [12]. Given that
t h ep r e v a l e n c eo fo b e s i t yi so nt h er i s e ,a n dt h a tC V Di s
an important cause of morbidity and mortality in Peru, its
risk factors and their measurements warrant further study
for this population. The purpose of the present study was to
investigate the extent to which measures of adiposity (BMI,
WC, WHR, WHtR, and VAI) can be used to predict elevated
C-reactive protein (CRP) and selected components of MetS:
elevated TG, reduced HDL, elevated BP, and elevated FG
among Peruvian adults.
2.Materialsand Methods
The data used for the present study were gathered as part
of the Prevalencia de Factores de Riesgo de Enfermedades
No-Transmisibles (prevalence of risk factors for noncom-
municable diseases) population-based study, known as the
FRENT study. Details of the study setting, sampling, and
data collection procedures have been described previously
[12, 13]. For the present analysis, we excluded participants
taking antidiabetic drugs (n = 30), lipid lowering drugs (n =
33), or antihypertensive drugs (n = 81). The ﬁnal analyzed
sample included1,518 participants, 952women (62.7%)and
566 men (37.3%).
Participants were interviewed by trained health profes-
sionalsusing astandardized instrument,previouslyvalidated
by the Pan American Health Organization (PAHO) and
approved by the WHO [14]. Interview questions collected
consisted of socio-demographic information, smoking sta-
tus, alcohol consumption, medical history, and level of
physical activity. Participants’ height and weight were mea-
sured in accordance with PAHO procedures with partic-
ipants wearing light clothing and no shoes [14]. Waist
circumference (cm) was measured around the point halfway
between the iliac crest and the sides of the lower ribs; the
hip circumference (cm) was measured using the point of
maximum girth around the buttocks.
Resting mean systolic and diastolic BP were calculated
as an average of two measurements: the ﬁrst taken after the
participant had been seated for ﬁve minutes or more, and
the second measure taken 30 minutes into the interview.
Bloodsamplesweredrawnfromparticipantsthedayafterthe
interview, and an individual had fasted for at least 12 hours.
Aliquots of serum samples were used to determine FG, TG,
HDL, and LDL concentrations using standard procedures
at the Peruvian National Institute of Health Laboratory in
Lima, Peru. Serum CRP concentrations were measured by
an ultrasensitive competitive immunoassay (Dade Behring,
Deerﬁeld, Illinois) at the University of Washington. All
laboratory procedureswere conductedwithoutknowledgeof
participants’ medical history.
All study participants provided informed consent, and
all research protocols were approved by Institutional Review
Boards of National Institute of Health (Lima, Peru), Dos de
Mayo Hospital (Lima, Peru), and Human Subjects Division
of the University of Washington (Seattle, WA, USA).
2.1. Variable Speciﬁcation. WHR was calculated as waist
circumference divided by hip circumference, and WHtR was
computed as waist circumference divided by height. VAI
was calculated according to the deﬁnition established by
Amato and colleagues [7], using VAI = 1 as the reference
for a nonobese participant with normal TG and HDL
concentrations
Men: VAI =
WC
39.68+ (1.88 ∗ BMI)
∗
TG
1.03
∗
1.31
HDL
,
Women: VAI =
WC
36.58+ (1.89 ∗ BMI)
∗
TG
0.81
∗
1.52
HDL
.
(1)
BMI was calculated as weight (kg) divided by height
squared (m2) and categorized using WHO guidelines (lean:
<18.5kg/m2; normal: 18.5–24.9kg/m2; overweight: 25.0–
29.9kg/m2;o b e s e≥30kg/m2). In accordance with the
NCEP diagnostic criteria, MetS components were deﬁned
as (1) elevated BP (mean value of systolic blood pres-
sure ≥130mmHg, mean value of diastolic blood pressure,
≥85mmHg); (2) abdominal obesity (waist circumference
>102cm in men and >88cm in women); (3) low HDL
(<40mg/dL in men and <50mg/dL in women); (4) elevated
TG (≥150mg/dL); (5) elevated FG (≥110mg/dL) or current
drug therapy for diabetes [5].
2.2. Statistical Analyses. Data were analyzed using Statistical
Package for the Social Sciences (version 17.0, SPSS Inc.,
Chicago, IL, USA) software. All analyses were stratiﬁed
by gender. Pearson Chi square test was used to compare
socio-demographic and behavioral characteristics between
men and women. Correlation between the four selected
MetS components and anthropometric measurements was
evaluated using Spearman’s rank coeﬃcients. Each anthro-
pometric measurement was divided ap r i o r iinto tertiles
and the prevalence of each MetS component was calculated
for each tertile. Categories of CRP were deﬁned by the
following tertiles: <0.81mg/L, 0.81–2.53mg/L, and >2.53
mg/L. Elevated CRP was deﬁned as being in the highest
tertile (>2.53mg/mL) [13]. Logistic regression proceduresInternational Journal of Hypertension 3
Table 1: Socio-demographic characteristics of the study population.
Characteristic Women N = 952 Men N = 566 P-value
N (%) N (%)
Age (years) .001
≤24 151 (15.9) 131 (23.1)
25–34 234 (24.6) 146 (25.8)
35–44 231 (24.3) 109 (19.3)
45–54 173 (18.2) 84 (14.8)
55–64 109 (11.4) 52 (9.2)
≥65 54 (5.7) 44 (7.8)
Education .001
≤6 years 165 (17.8) 59 (10.7)
7–12 years 429 (46.4) 262 (47.5)
≥12 years 331 (35.8) 230 (41.7)
Smokingstatus <.001
Never smoker 800 (84.0) 315 (55.7)
Pervious smoker 60 (6.3) 69 (12.2)
Current smoker 92 (9.7) 182 (32.2)
Currently employed <.001
No 530 (55.8) 194 (34.4)
Yes 419 (44.2) 370 (65.6)
Alcohol consumption <.001
Low 572 (60.1) 198 (35.0)
Moderate 371 (39.0) 330 (58.3)
Excessive 9 (0.9) 38 (6.7)
Body mass index (kg/m2) .002
Underweight (<18.5) 8 (0.8) 10 (1.8)
Normal (18.5–24.9) 402 (42.2) 219 (38.7)
Overweight (25.0–29.9) 339 (35.6) 247 (43.6)
Obesity (≥30.0) 203 (21.3) 90 (15.9)
Leisure time physical activity .002
No 217 (22.8) 168 (29.7)
Yes, <150 minutes/week 637 (66.9) 328 (58.0)
Yes, ≥150 minutes/week 98 (10.3) 70 (12.4)
∗All P values were obtained using Pearson Chi Square.
were used to estimate odd ratios (ORs) and 95% conﬁdence
intervals (95% CI) of components of MetS and CRP
according to combinations of overall (BMI) and central
adiposity (WC) measures. For these analyses, participants
were grouped ap r i o r ias follows: low BMI and low WC
(the reference group), high BMI and low WC, low BMI and
high WC, and high BMI and high WC. Because there were
few subjects in the low BMI and high WC category, those
with low BMI and high WC were grouped with high BMI
and low WC. Potential-confounding variables were selected
for assessment ap r i o r ion the basis of their hypothesized
relationship with adiposity measures and cardiometabolic
risk. The presence of confounding was empirically assessed
by entering potential covariates into a logistic regression
model one at a time and by comparing the adjusted and
unadjusted ORs. Final logistic regression models included
covariates that altered unadjusted ORs by at least 10% [15].
For all analyses, signiﬁcance was set at a P value of less than
.05. Finally, receiver operating characteristic (ROC) curves
witharea underthecurve(AUC)were usedtoevaluatewhich
measure of adiposity (BMI, WC, WHR, WHtR, VAI) most
accurately predicted the diﬀerent components of MetS.
3.Results
Characteristics of study participants are summarized in
Table 1. The mean age of study participants was 39.3 years
(38.3 years for men and 39.9 years for women). Overall,
men tended to be younger, more educated, and more likely
to be employed. Men reported smoking and consuming4 International Journal of Hypertension
Table 2: Spearman’s rank correlation coeﬃcients for anthropometric measurements and metabolic syndrome components.
BMI (kg/m2)W C ( c m ) W H R W H t R V A I
Men
Fasting plasma glucose (mg/dL) 0.330 0.292 0.205 0.304 0.222
Triglyceride (mg/dL) 0.462 0.461 0.335 0.439 0.948
HDL (mg/dL) −0.291 −0.286 −0.188 −0.247 −0.664
Systolic blood pressure (mmHg) 0.273 0.301 0.255 0.291 0.188
Diastolic blood pressure (mmHg) 0.331 0.330 0.298 0.316 0.247
Women
Fasting plasma Glucose (mg/dL) 0.306 0.301 0.107 0.301 0.250
Triglyceride (mg/dL) 0.437 0.455 0.226 0.451 0.933
HDL (mg/dL) −0.220 −0.209 −0.194 −0.213 −0.618
Systolic blood pressure (mmHg) 0.296 0.323 0.180 0.304 0.271
Diastolic blood pressure (mmHg) 0.265 0.265 0.164 0.262 0.227
The P values for all Spearman’s rank correlations listed are less than or equal to.001.
alcohol more frequently than women. On the basis of BMI
values, men tended to be overweight (43.6% versus 35.6%
of women), but women were more commonly obese (21.3%
versus 15.9%, resp.).
Spearman’s rank correlation coeﬃcients were used to
evaluate associations between anthropometric measure-
ments and components MetS (Table 2). The strongest
correlationwasbetweenVAIwithtriglycerideconcentrations
(men: r = 0.948, women: r = 0.933), followed by VAI
with HDL concentrations (men: r =− 0.664, women: r =
−0.618);however, thiswasexpected asTG andHDLare used
to calculate VAI. For all measures of adiposity, triglyceride
concentrations had the strongest positive correlation for
men: BMI (r = 0.462), WC (0.461), WHtR (r = 0.439),
and WHR (r = 0.335) and for women: WC (r = 0.455),
WHtR (r = 0.451), BMI (r = 0.437), and WHR (r =
0.226). Of the measures of adiposity studied, BMI was most
positively correlated with FG for both men (r = 0.330) and
women (r = 0.306). Other than VAI, BMI was most strongly
negatively correlated with reduced HDL.
Table 3 shows for both genders that the prevalence of
elevated FG, BP, TG, and reduced HDL increased progres-
sively as tertiles of each of the measures of adiposity studied
increased. Table 4 shows the risk of MetS components in
relation to central adiposity measures for men and women,
adjusting for age, education, smoking, leisure time physical
activity,andalcoholconsumption.ComparedtothelowBMI
& low WC (reference group), men with high BMI or high
WC had 3.40 higher odds of having elevated TG (95% CI:
2.21–5.23), while men having both high BMI and high WC
had an even higher adjusted odds ratio (AOR) (AOR: 3.89
95% CI: 2.15–7.04).For women, these AORswere 1.72 (95%
CI: 1.02–2.91) and 4.64 (95% CI: 3.05–7.06), respectively.
Men having either high BMI or high WC had 2.04 increased
oddsofreducedHDL(95%CI:1.38–3.02),whilemenhaving
high BMI and high WC had even higher odds for reduced
HDL (AOR: 3.97 95% CI: 2.20–7.18). For women, these
AORswere1.29(95%CI:0.89–1.88)and2.71(95%CI:1.95–
3.75), respectively. Men having either high BMI or high WC
had 1.85 higher odds for elevated BP (95% CI: 1.18–2.88),
and men in the high BMI & high WC category had even
higher odds (AOR: 2.93, 95% CI: 1.61–5.32). For women in
the same anthropometric measures categories, these AORs
were 1.45 (95% CI: 0.82–2.58) and 2.09 (95% CI: 1.32–
3.32), respectively. Men having just one of the adiposity
measurements ofhigh BMIorhighWC had 1.66higherodds
(95%CI:0.86–3.23)ofhavingelevatedFG,whilemenhaving
both high BMI and high WC had 2.32 higher odds of having
elevated FG (95% CI: 1.03–5.19).For women with high BMI
or high WC, the AOR was 1.14 (95% CI: 0.53–2.43), and
for women with both high BMI and high WC, the AOR was
2.92 (95% CI: 1.65–5.16). Men having high BMI or high
WC had 1.61 higher odds of having elevated CRP (95% CI:
1.08–2.41), and these odds increased for men having both
high BMI and high WC (AOR: 1.86 95% CI: 1.05–3.31). For
women, this association was not signiﬁcant: 1.23 (95% CI:
0.83–1.83) for those in the high BMI or high WC category,
and among high BMI & high WC category: 1.15 (95% CI:
0.82–1.60).
Figures 1 and 2 show the level how adiposity measures
predict each of the MetS components studied. As expected
due to inclusion in the formula, VAI was the best predictor
for elevated TG (area under curve [AUC] = 0.98) among
men and women (AUC = 0.97), and reduced HDL for men
(AUC = 0.82) and women (AUC = 0.80). VAI and BMI were
the best predictors for FG for men (AUC = 0.67 and 0.67,
resp.), while for women, WC and WHtR were the best pre-
dictors(AUC:0.72and0.72,resp.).Forelevatedtriglycerides,
WC was the best predictor (AUC: 0.73) for men while for
women, WHRwasthebest(AUC:0.65).ForelevatedBP, WC
wasthebest predictor(AUC:0.66)formenwhile forwomen,
WHtR was the best (AUC = 0.70). For reduced HDL, BMI
was the strongest predictor for both men (AUC: 0.66) and
women (AUC = 0.62).
4.Discussion
Toourknowledge,noresearch haspreviouslybeenpublished
assessing the multiple adiposity measures in predicting
MetS among Peruvian adults. This study has demonstratedInternational Journal of Hypertension 5
Table 3:Prevalenceofmetabolicsyndromecomponentsinrelationto varyingdegree ofadiposityasassessedusingdiﬀerent anthropometric
measures.
Measurement of obesity
Metabolic syndrome components
Elevated FG High TG Low HDL Elevated BP
%% %%
Among Men N = 64 N = 209 N = 252 N = 154
Body mass index Tertile1 (<24.2) 17.2 15.8 21.4 22.1
(kg/m2)T e r t i l e 2 (23.3–27.6) 28.1 33.0 36.5 27.9
Tertile3 (>27.6) 54.7 51.2 42.1 50.0
Waist circumference Tertile1 (<88.0) 17.2 13.0 24.7 20.7
(cm) Tertile2 (88.0–97.0) 35.9 38.0 33.9 29.9
Tertile3 (≥97.0) 46.9 49.0 41.4 49.4
Waist-to-hip ratio Tertile1 (<0.91) 23.4 17.9 27.5 23.5
Tertile2 (0.91–0.96) 31.3 35.7 33.9 30.7
Tertile3 (>0.96) 45.3 46.4 38.6 45.8
Waist-to-height ratio Tertile1 (<0.52) 17.2 13.0 20.3 20.8
Tertile2 (0.52–0.58) 29.7 37.5 39.4 27.9
Tertile3 (≥0.58) 53.1 49.5 40.2 51.3
VAI Tertile1 (<2.85) 17.2 0.0 11.2 23.4
Tertile2 (2.85–5.47) 29.7 15.4 29.9 35.7
Tertile3 (≥5.47) 53.1 84.6 59.0 40.9
Among women N = 110 N = 253 N = 575 N = 187
Body mass index Tertile1 (<24.1) 16.4 15.0 26.6 19.8
(kg/m2)T e r t i l e 2 (24.1–28.0) 23.6 28.5 33.0 29.9
Tertile3 (>28.0) 60.0 56.5 40.3 50.3
Waist circumference Tertile1 (<83.0) 12.7 10.3 29.3 14.4
(cm) Tertile2 (83.0–93.0) 28.2 35.6 32.9 30.5
Tertile3 (≥93.0) 59.1 54.2 37.8 55.1
Waist-to-hip ratio Tertile1 (<0.87) 20.0 20.2 28.9 20.9
Tertile2 (0.87–0.92) 32.7 30.8 33.6 36.4
Tertile3 (>0.92) 47.3 49.0 37.5 42.8
Waist-to-height ratio Tertile1 (<0.54) 11.8 12.3 27.0 15.5
Tertile2 (0.54–0.61) 26.4 30.8 34.1 26.7
Tertile3 (≥0.61) 61.8 56.9 38.9 57.8
VAI Tertile1 (<3.00) 12.7 0.0 17.9 15.0
Tertile2 (3.00–5.59) 21.8 7.9 32.1 29.9
Tertile3 (≥5.59) 65.5 92.1 50.0 55.1
FG: fasting plasma glucose; TG: triglyceride; HDL: high density lipoprotein-cholesterol; BP: blood pressure; VAI: visceral adiposity index.
the association between adiposity measures and MetS
components. First, all adiposity measures were statistically
signiﬁcantly correlated with all MetS components studied.
The prevalence of these factors increased gradually with
increasing tertiles for each adiposity measure. Second, men
and women with high overall and central adiposity values
(i.e., high BMI & high WC) consistently had higher odds
of having cardiometabolic risk factors when compared
with their leaner counterparts. Notably, elevated CRP was
associatedwithhighBMIand/orhighWCformen.However,
no such association was observed among women. This is
in agreement with previous studies that reported a gender
diﬀerence CVD risk in relation to CRP levels [13]. WC was
the best measure of adiposity to predict elevated BP in men.
On the other hand, WC was most predictive of elevated FG
in women.
Our observations are generally consistent with some,
though not all, prior studies. Medina-Lezama et al. reported
that WC was a better and accurate measure of CVD risk
among Andean adults [16]. Similarly, other investigators
reported that WC was a better predictor of CVD risk factors
(better than BMI) among non-Hispanic black, Mexican
American, and non-Hispanic white participants of the third
National Health and Nutrition Examination Survey [17].
Additionally, Menke and colleagues noted that WC was a
better predictor of hypertension, diabetes, low HDL choles-
terol, elevated triglycerides, and insulin resistance than BMI
[18]. Ourﬁndings and those of others[16–18]a r es o m e w h a t6 International Journal of Hypertension
Table 4: Risk of metabolic syndrome components in relation to visceral adiposity.
Low BMI & Low WC High BMI or High WC∗∗ High BMI and High WC
OR (CI) OR (CI) P value (SE) OR (CI) P value (SE)
Among Women
Elevated triglyceride 1.00 (Reference) 2.44 (1.50–3.98) 0.000 (0.249) 6.47 (4.37–9.58) 0.000 (0.200)
Adjusted∗ 1.00 (Reference) 1.72 (1.02–2.91) 0.042 (0.268) 4.64 (3.05–7.06) 0.000 (0.214)
Reduced HDL 1.00 (Reference) 1.28 (0.89–1.83) 0.184 (0.183) 2.64 (1.96–3.56) 0.000 (0.152)
Adjusted∗ 1.00 (Reference) 1.29 (0.89–1.88) 0.178 (0.191) 2.71 (1.95–3.75) 0.000 (0.167)
Elevated BP 1.00 (Reference) 1.99 (1.20–3.30) 0.007 (0.258) 3.40 (2.27–5.08) 0.000 (0.205)
Adjusted∗ 1.00 (Reference) 1.45 (0.82–2.58) 0.206 (0.294) 2.09 (1.32–3.32) 0.002 (0.236)
Elevated fasting glucose 1.00 (Reference) 1.70 (0.83–3.45) 0.144 (0.362) 4.34 (2.54–7.41) 0.000 (0.273)
Adjusted∗ 1.00 (Reference) 1.14 (0.53–2.43) 0.744 (0.389) 2.92 (1.65–5.16) 0.000 (0.291)
Elevated CRP 1.00 (Reference) 1.46 (1.00–2.14) 0.049 (0.193) 1.29 (0.95–1.76) 0.102 (0.157)
Adjusted∗ 1.00 (Reference) 1.23 (0.83–1.83) 0.310 (0.203) 1.15 (0.82–1.60) 0.429 (0.171)
Among Men
Elevated Triglyceride 1.00 (Reference) 3.81 (2.53–5.75) 0.000 (0.209) 5.65 (3.20–9.96) 0.000 (0.289)
Adjusted∗ 1.00 (Reference) 3.40 (2.21–5.23) 0.000 (0.220) 3.89 (2.15–7.04) 0.000 (0.303)
Reduced HDL 1.00 (Reference) 2.21 (1.53–3.20) 0.000 (0.189) 4.33 (2.48–7.57) 0.000 (0.284)
Adjusted∗ 1.00 (Reference) 2.04 (1.38–3.02) 0.000 (0.199) 3.97 (2.20–7.18) 0.000 (0.302)
Elevated BP 1.00 (Reference) 1.98 (1.29–3.04) 0.002 (0.218) 3.67 (2.08–6.49) 0.000 (0.291)
Adjusted∗ 1.00 (Reference) 1.85 (1.18–2.88) 0.007 (0.227) 2.93 (1.61–5.32) 0.000 (0.305)
Elevated fasting glucose 1.00 (Reference) 2.10 (1.11–3.96) 0.022 (0.324) 3.61 (1.67–7.81) 0.001 (0.394)
Adjusted∗ 1.00 (Reference) 1.66 (0.86–3.23) 0.135 (0.339) 2.32 (1.03–5.19) 0.041 (0.412)
Elevated CRP 1.00 (Reference) 1.66 (1.13–2.43) 0.010 (0.195) 2.04 (1.18–3.52) 0.010 (0.278)
Adjusted∗ 1.00 (Reference) 1.61 (1.08–2.41) 0.019 (0.204) 1.86 (1.05–3.31) 0.034 (0.293)
∗Adjusted for age, education, smoking, leisure time physical activity, and alcohol consumption.
∗∗Low BMI and High WC combined with High BMI and Low WC.
inconsistent with other reports. For instance, Wildman and
colleaguesreportedthatWCandBMIwereequallypredictive
of CVD risk [19]. Moreover, results from a 2007 meta-
analysis [20] suggested that measures of overall obesity
(BMI) and measures of central obesity (WHR and WC)
performedequallywell inpredictingincidenttype2diabetes.
Other investigators, however, have reported that WHtR is
the best predictor of CVD risk and other cardiometabolic
risk factors (including hypertension and dyslipidemia) than
other anthropometric measurements [19–26]. In a meta-
analysis of indices of abdominal obesity, Lee et al. reported
that BMI was the poorest discriminator, whilst WHtR
was the best discriminator for hypertension, diabetes, and
dyslipidemia for both men and women [10]. Herrera and
colleagues also reported that WHtR was the most accurate
measure of coronary heart disease risk, followed by WC, and
BMI, in their study [22]. Finally, some have suggested that
WHR, because it takes body fat distribution into account
by showing abdominal and peripheral adiposity, may be the
ideal measurement of adiposity [27]. However, we found
WHR to have the weakest correlation and lowest AUC values
of the adiposity measures for all MetS components, with
the exception of elevated BP in men. VAI appeared to be
the best predictor of elevated TG and low HDL in our
study. However, it is important to note that triglyceride and
HDL concentrations are included in the calculation of VAI
values. Our observation of higher odds of cardiometabolic
risks among men and women with combined high overall
adiposityandcentraladiposity(i.e.,highBMandWCvalues)
is biologically plausible, as intra-abdominal fat is known to
be highly associated with all components of MetS [28].
As noted by Paniagua et al. [26], heterogeneity in study
ﬁndings across studies that have assessed cardiometabolic
risk factors in relation to indices of adiposity may be
attributable to diﬀerences in race/ethnicity, age, and gender
distributions of participants across study populations. A
number of investigators have reported diﬀerences in the
predictive value of obesity indicators according to ethnicity
[29, 30] .V a z q u e ze ta l .n o t e dt h a tc e n t r a lo b e s i t yw a sa
stronger predictor of incident type 2 diabetes than were
measures oftotalbody fat [20]. However,measures ofoverall
obesity were better predictor of type 2 diabetes in US
and European Caucasian [31]. Though no anthropometric
measurement was consistently the best predictor for MetS
among the present population of Peruvian adults, we noted
that VAI, WC, and WHtR to be the best predictors for
individual MetS components.
Strengths of our study include the extensive CVD risk-
factor data available for study participants and the unique
opportunityto assess these risk factors ina population-based
sample representative of adult residents of Lima and Callao,
Peru. Limitations of our study include the cross-sectional
design which did not allow us to assess the temporality of
the relation between the adiposity measures and metabolicInternational Journal of Hypertension 7
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Figure 1: Receiver operating characteristic (ROC) curves with area under curve (AUC) and 95% conﬁdence intervals of body mass index
(BMI), waist circumference (WC), waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) for predicting cardiovascular disease risk
factors amongPeruvian men.
syndrome components. Somenonsystematic error in report-
ing of smoking history, physical activity, and other covariates
may have occurred. Additionally, despite adjustment for
multiple confounders, residual confounding by unmeasured
or imprecisely measured covariates may persist. Finally,
concordance of our study results with previous reports from
geographically, racially, and ethnically diverse populations,
in part, attenuates these concerns.
Although the best adiposity measurement for predicting
CVD remains controversial, in our study most measures
of adiposity were correlated with the cardiometabolic fac-
tors of interest. The results of our study underscore the
importance of using simple, broadly applicable measures
of adiposity such as WC and WHtR in community-based
epidemiologicstudies.Theserelativelyinexpensive andeasily
obtained measures are useful for assessing cardiovascular8 International Journal of Hypertension
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Figure 2: Receiver operating characteristic (ROC) curves with area under curve (AUC) and 95% conﬁdence intervals of body mass index
(BMI), waist circumference (WC), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR) for predicting cardiovascular disease risk
factors amongPeruvian Women.
disease risk in nonclinical settings. Though the various
measurements each have advantages and disadvantages, it
is evident that, to date, no single measurement can be
identiﬁed as the optimal choice for CVD prediction on its
own. To this eﬀect, the United States National Institutes
of Health (NIH) now recommends the use of WC in
conjunction with BMI as a complementary indicator of
health risk among normal and overweigh subjects [32].
The overall results of our study showed that measures of
adiposity are correlated with cardiovascular risk among
Peruvian adults. Investigators in Latin America have called
for a country-speciﬁc epidemiological data to help bring
public health policy changes for surveillance, prevention,
and intervention [33]. The high prevalence of MetS, obesity,
and observed associations of cardiometabolic risks with
adiposity measures reported in this study calls for increased
eﬀorts aimed towards clinical preventive services to identify
and control the existing metabolic abnormalities amongInternational Journal of Hypertension 9
patients. Additionally, development and implementation of
public health programs that promote healthful behaviors
including increased physical activity, eating balanced diets,
and avoidance ofadult weight gain are needed to help reduce
the burden of noncommunicable diseases among Peruvian
adults.
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